Clinical Trials Browser

Diarylheptanoids × 1 year × Clear all

NCT06626230 2026-05-18

Safety of Anal Curcumin

Phase 1 Recruiting

Neoplasms

NCT03598309 2026-02-27

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Phase 2 Active not recruiting

Lung Diseases, Lung Neoplasms